ArticleFrontiers in medicine2022

DOK2 Has Prognostic and Immunologic Significance in Adults With Acute Myeloid Leukemia: A Novel Immune-Related Therapeutic Target.

Jiaxuan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.